Looking at this filing, I need to identify the key facts from this 10-K for Azenta, Inc. for fiscal year ended September 30, 2026, filed on NASDAQ:AZTA. Let me check the substantive disclosure content - the filing contains business information, financial data references, share counts, market cap figures, and other substantive disclosures well beyond 150 words. Key facts from the filing: - Company: Azenta, Inc. - Ticker: AZTA on The Nasdaq Stock Market LLC - Form: 10-K, fiscal year ended September 30, 2026 - Aggregate market value of non-affiliate shares as of March 31, 2026: approximately $734,126,229 - Closing price on March 31, 2026: $21.13 - Shares outstanding as of March 31, 2026: 46,091,424 - Shares outstanding as of November 16, 2026: 41,941,520 - Large accelerated filer - Material weakness in internal control over financial reporting mentioned - Restructuring plan approved October 5, 2026 - Acquisition of SynPlexity Inc. mentioned - License and supply arrangements with Elegen Corp. mentioned - CEO transition mentioned

Azenta, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on November 19, 2026, covering the fiscal year ended September 30, 2026.

Key Highlights

  • Shares outstanding: As of November 16, 2026, 41,941,520 shares of common stock, $0.01 par value, were outstanding, down from 46,091,424 shares as of March 31, 2026, according to the filing.
  • Non-affiliate market value: The aggregate market value of common stock held by non-affiliates was approximately $734,126,229 as of March 31, 2026, based on a closing price of $21.13 per share on that date.
  • Filer status: The company is classified as a large accelerated filer, as indicated in the filing.
  • Material weakness: The filing references "the remediation of the remaining material weakness in our internal control over financial reporting" as a subject of forward-looking statements.
  • Restructuring plan: The filing references a restructuring plan approved on October 5, 2026, with implementation, costs, and expected savings cited as forward-looking matters.
  • CEO transition: The filing identifies "the transition of our Chief Executive Officer and the search for a permanent Chief Executive Officer" as a subject of forward-looking statements.
  • Recent transactions: The filing references the integration of SynPlexity Inc. and performance of license and supply arrangements with Elegen Corp.

Azenta's Fiscal Year 2026 Annual Disclosure: Key Figures and Operational Context

Azenta, Inc. (NASDAQ:AZTA), a Delaware-incorporated company headquartered at 200 Summit Drive, 6th Floor, Burlington, Massachusetts, submitted its Form 10-K annual report for the fiscal year ended September 30, 2026. The filing identifies the company as a large accelerated filer and confirms that its common stock, $0.01 par value, is listed on The Nasdaq Stock Market LLC under the trading symbol AZTA.

According to the filing, the aggregate market value of shares held by non-affiliates was approximately $734,126,229 as of March 31, 2026, calculated using the closing price of $21.13 per share on that date. The share count declined between the two reference dates disclosed: 46,091,424 shares were outstanding as of March 31, 2026, compared with 41,941,520 shares as of November 16, 2026. The filing does not explain the reason for the reduction in shares outstanding within the sections provided.

The filing's forward-looking statements section identifies several ongoing matters the company characterizes as subject to uncertainty. These include the remediation of a remaining material weakness in internal control over financial reporting, a restructuring plan approved on October 5, 2026, the integration of SynPlexity Inc., performance under license and supply arrangements with Elegen Corp., and a search for a permanent Chief Executive Officer. The filing also cites potential impacts from tariffs, changes in trade policy, export controls, and biotechnology procurement restrictions, including under the BIOSECURE Act, as forward-looking matters. The company notes that forward-looking statements are subject to risks and uncertainties described in Part I, Item 1A "Risk Factors" and other regulatory filings, and that it undertakes no obligation to update them except as required by law.

What Was Disclosed

Azenta, Inc. filed its fiscal year 2026 Form 10-K, disclosing share counts, a non-affiliate market capitalization of approximately $734,126,229 as of March 31, 2026, an ongoing material weakness remediation, a CEO search, and a restructuring plan approved in October 2026.